PENZBERG, Germany--(BUSINESS WIRE)-- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler® 480 ...
The LightCycler PRO System is designed to be the most advanced qPCR technology for both clinical diagnostics and research. The new system will advance personalised healthcare and support outbreak ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler® 480 System, a real-time polymerase chain ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. launch of the latest addition to the company's real-time PCR portfolio of LightCycler® instruments for use in research, the LightCycler Nano ...
PENZBERG, Germany--(BUSINESS WIRE)-- Roche (SIX:RO)(SIX:ROG)(OTCQX:RHHBY) and Ghent University (Belgium) have signed an agreement for the use of Roche's LightCycler® 1536 Instrument in various cancer ...
We will discuss the Digital LightCycler System, a digital PCR (dPCR) system for DNA and RNA with 6-color capability for flexible, multiplexed biomarker detection. With advances in sensitivity, ...
INDIANAPOLIS, April 6, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results